PPAR-mediated activity of phthalates: A link to the obesity epidemic?

Molecular and Cellular Endocrinology

Volumn 304, Issue 1-2, 2009, Pages 43-48

  Desvergne, Béatrice ^a   Feige, Jérôme N ^a   Casals Casas, Cristina ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Metabolic disruptor; Phthalates; Selective PPAR modulators

Indexed keywords

CARBOHYDRATE; CELL NUCLEUS RECEPTOR; ENDOCRINE DISRUPTOR; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; XENOBIOTIC AGENT;

CARBOHYDRATE METABOLISM; ENDOCRINE DISEASE; ENVIRONMENTAL EXPOSURE; EPIDEMIC; EUROPE; HUMAN; LIPID METABOLISM; LIPOPHILICITY; METABOLITE; NONHUMAN; NORTH AMERICA; OBESITY; POLLUTANT; PRIORITY JOURNAL; REVIEW; SENSOR; WILDLIFE;

ANIMALS; ENDOCRINE DISRUPTORS; ENDOCRINE SYSTEM; ENVIRONMENTAL POLLUTANTS; HUMANS; LIGANDS; OBESITY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHTHALIC ACIDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; XENOBIOTICS;

EID: 67349261714     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.02.017     Document Type: Review

References (50)

1. Arcadi F.A., Costa C., Imperatore C., Marchese A., Rapisarda A., Salemi M., Trimarchi G.R., and Costa G. Oral toxicity of bis(2-ethylhexyl) phthalate during pregnancy and suckling in the Long-Evans rat. Food Chem. Toxicol. 36 11 (1998) 963-970
2. ATSDR, 1993. Toxicological profile for di-(2-ethylhexyl) phthalate (Update), TP-92/05. US Dept Health and Human Services, Agency for Toxic Substances and Disease Registry, Atlanta, GA, 147.
3. Baillie-Hamilton P.F. Chemical toxins: a hypothesis to explain the global obesity epidemic. J. Altern. Complement. Med. 8 2 (2002) 185-192
4. Bility M.T., Thompson J.T., McKee R.H., David R.M., Butala J.H., Vanden Heuvel J.P., and Peters J.M. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicol. Sci. 82 1 (2004) 170-182
5. Casals-Casas C., Feige J.N., and Desvergne B. Interference of pollutants with PPARs: endocrine disruption meets metabolism. Int. J. Obesity. 32 Suppl. 6 (2008) S53-S61
6. Corton J.C., Anderson S.P., and Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 491-518
7. Cronet P., Petersen J.F., Folmer R., Blomberg N., Sjoblom K., Karlsson U., Lindstedt E.L., and Bamberg K. Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure 9 8 (2001) 699-706
8. Desvergne B., Michalik L., and Wahli W. Sensors for metabolic control: a regulatory network of nuclear receptors. In: Goffin V., and Kelly P.A. (Eds). Hormone Signaling (2002), Kluwer Academic Publishers, Norwell 283-304 Chapter 14
9. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 5 (1999) 649-688
10. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., and Wahli W. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68 (1992) 879-887
11. Faouzi M.A., Dine T., Gressier B., Kambia K., Luyckx M., Pagniez D., Brunet C., Cazin M., Belabed A., and Cazin J.C. Exposure of hemodialysis patients to di-2-ethylhexyl phthalate. Int. J. Pharm. 180 1 (1999) 113-121
12. Feige J.N., Gelman L., Michalik L., Desvergne B., and Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res. 45 2 (2006) 120-159
13. Feige J.N., Gelman L., Rossi D., Zoete V., Metivier R., Tudor C., Anghel S.I., Grosdidier A., Lathion C., Engelborghs Y., Michielin O., Wahli W., and Desvergne B. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J. Biol. Chem. 282 26 (2007) 19152-19166
14. Feige J.N., Gelman L., Tudor C., Engelborghs Y., Wahli W., and Desvergne B. Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J. Biol. Chem. 280 18 (2005) 17880-17890
15. Feldman D. Estrogens from plastic-are we being exposed?. Endocrinology 138 5 (1997) 1777-1779
16. Gelman L., Feige J.N., and Desvergne B. Molecular basis of selective PPARgamma modulation for the treatment of Type 2 diabetes. Biochim. Biophys. Acta 1771 8 (2007) 1094-1107
17. Gelman L., Feige J.N., Tudor C., Engelborghs Y., Wahli W., and Desvergne B. Integrating nuclear receptor mobility in models of gene regulation. Nucl. Recept. Signal 4 (2006) e010
18. Grun F., and Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev. Endocr. Metab. Disord. 8 2 (2007) 161-171
19. Grun F., Watanabe H., Zamanian Z., Maeda L., Arima K., Cubacha R., Gardiner D.M., Kanno J., Iguchi T., and Blumberg B. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol. Endocrinol. 20 9 (2006) 2141-2155
20. Heindel J.J. Endocrine disruptors and the obesity epidemic. Toxicol. Sci. 76 2 (2003) 247-249
21. Honkakoski P., and Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 347 Pt 2 (2000) 321-337
22. Hurst C.H., and Waxman D.J. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol. Sci. 74 2 (2003) 297-308
23. Issemann I., Prince R., Tugwood J., and Green S. A role for fatty acid and liver fatty acid binding protein in peroxisome proliferation?. Biochem. Soc. Transact. 20 (1992) 824-827
24. Kevy S.V., and Jacobson M.S. Hepatic effects of a phthalate ester plasticizer leached from poly(vinyl chloride) blood bags following transfusion. Environ. Health Perspect. 45 (1982) 57-64
25. Lapinskas P.J., Brown S., Leesnitzer L.M., Blanchard S., Swanson C., Cattley R.C., and Corton J.C. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver. Toxicology 207 1 (2005) 149-163
26. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., and Gonzalez F.J. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell Biol. 15 (1995) 3012-3022
27. Li L.H., Jester Jr. W.F., and Orth J.M. Effects of relatively low levels of mono-(2-ethylhexyl) phthalate on cocultured Sertoli cells and gonocytes from neonatal rats. Toxicol. Appl. Pharmacol. 153 2 (1998) 258-265
28. Masuyama H., Hiramatsu Y., Kunitomi M., Kudo T., and MacDonald P.N. Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate Pregnane X receptor-mediated transcription. Mol. Endocrinol. 14 3 (2000) 421-428
29. Muerhoff A.S., Griffin K.J., and Johnson E.F. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J. Biol. Chem. 267 27 (1992) 19051-19053
30. Newbold R.R., Padilla-Banks E., Jefferson W.N., and Heindel J.J. Effects of endocrine disruptors on obesity. Int. J. Androl. 31 2 (2008) 201-208
31. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., and Millburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395 (1998) 137-143
32. NTP-CERHRexpertpanel, 2006. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Di(2-ethylhexyl)phthalate Ntp Cerhr Mon, http://cerhr.niehs.nih.gov/chemicals/dehp.
33. Peters J.M., Taubeneck M.W., Keen C.L., and Gonzalez F.J. Di(2-ethylhexyl) phthalate induces a functional zinc deficiency during pregnancy and teratogenesis that is independent of peroxisome proliferator-activated receptor-alpha. Teratology 56 5 (1997) 311-316
34. Rusyn I., Peters J.M., and Cunningham M.L. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit. Rev. Toxicol. 36 5 (2006) 459-479
35. Scheer N., Ross J., Rode A., Zevnik B., Niehaves S., Faust N., and Wolf C.R. A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J. Clin. Invest. 118 9 (2008) 3228-3239
36. Sekar R.B., and Periasamy A. Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J. Cell Biol. 160 5 (2003) 629-633
37. Shah Y.M., Morimura K., Yang Q., Tanabe T., Takagi M., and Gonzalez F.J. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol. Cell Biol. 27 12 (2007) 4238-4247
38. Shi G.Q., Dropinski J.F., Zhang Y., Santini C., Sahoo S.P., Berger J.P., Macnaul K.L., Zhou G., Agrawal A., Alvaro R., Cai T.Q., Hernandez M., Wright S.D., Moller D.E., Heck J.V., and Meinke P.T. Novel 2, 3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activity. J. Med. Chem. 48 17 (2005) 5589-5599
39. Stahlhut R.W., van Wijngaarden E., Dye T.D., Cook S., and Swan S.H. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ. Health Perspect. 115 6 (2007) 876-882
40. Stanley L.A., Horsburgh B.C., Ross J., Scheer N., and Wolf C.R. PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab. Rev. 38 3 (2006) 515-597
41. Sueyoshi T., Kawamoto T., Zelko I., Honkakoski P., and Negishi M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274 10 (1999) 6043-6046
42. Tremblay A., and Chaput J.P. About unsuspected potential determinants of obesity. Appl. Physiol. Nutr. Metab. 33 4 (2008) 791-796
43. Troisi G.M., and Mason C.F. PCB-associated alteration of hepatic steroid metabolism in harbor seals (Phoca vitulina). J. Toxicol. Environ. Health A 61 8 (2000) 649-655
44. Tudor C., Feige J.N., Pingali H., Lohray V.B., Wahli W., Desvergne B., Engelborghs Y., and Gelman L. Association with coregulators is the major determinant governing peroxisome proliferator-activated receptor mobility in living cells. J. Biol. Chem. 282 7 (2007) 4417-4426
45. Wallrabe H., and Periasamy A. Imaging protein molecules using FRET and FLIM microscopy. Curr. Opin. Biotechnol. 16 1 (2005) 19-27
46. Wams T.J. Diethylhexylphthalate as an environmental contaminant-a review. Sci. Total Environ. 66 (1987) 1-16
47. Ward J.M., Peters J.M., Perella C.M., and Gonzalez F.J. Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice. Toxicol. Pathol. 26 2 (1998) 240-246
48. Wouters F.S., Verveer P.J., and Bastiaens P.I. Imaging biochemistry inside cells. Trends Cell Biol. 11 5 (2001) 203-211
49. Yang Q., Nagano T., Shah Y., Cheung C., Ito S., and Gonzalez F.J. The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha. Toxicol. Sci. 101 1 (2008) 132-139
50. Zoete V., Grosdidier A., and Michielin O. Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochim. Biophys. Acta 1771 8 (2007) 915-925